Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. hyscreen

HYscreen

A fast, cost-effective breath analysis technology for Helicobacter pYlori screening at both large and small scale.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 HYscreen project word cloud

Explore the words cloud of the HYscreen project. It provides you a very rough idea of what is the project "HYscreen" about.

market    incidence    scientific    population    helicobacter    global    solutions    detects    inconvenient    treatment    sampling    preventing    lower    feasibility    diagnosis    doors    avoiding    biopsies    ultimately    programs    ulcers    give    healthcare    cheaper    infection    breath    costly    expensive    innovation    validation    offers    final    mouthpiece    pylori    rapid    bill    diagnostics    lymphoma    fast    affordable    impetus    protection    secondary    bedfont    exhaled    reduce    absorption    trials    optimizing    link    simpler    c12    oxide    quicker    screening    billion    plan    optimization    convenience    commercially    solution    aesthetics    thermal    close    ulceration    endoscopies    ammonia    primary    air    consequently    business    accuracy    respectively    expertise    usa    portable    too    66    savings    time    duodenal    nitrogen    prototype    clinical    device    asia    gastric    sensor    decisions    diagnostic    monitoring    simplicity    biomarker    urea    infections    realized    hyscreen    shorten    cancer    oxidizer    answering    tests    entrapment    unnecessary    invasive    ltd    though    care   

Project "HYscreen" data sheet

The following table provides information about the project.

Coordinator		 Bedfont Scientific Limited 

Organization address
address: Station Yard, Station Road
city: Maidstone
postcode: ME17 1JA
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country United Kingdom [UK]
 Project website https://www.bedfont.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-05-01   to  2015-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    Bedfont Scientific Limited UK (Maidstone) coordinator 50˙000.00

Map

 Project objective

The increasing incidence of Helicobacter (H.) pylori infections and their close link with gastric cancer, gastric lymphoma, duodenal and gastric ulceration, give impetus to the H. pylori diagnostics market. Existing solutions are too costly, inconvenient and invasive; have a long analysis time or need technical expertise to analyse. Bedfont Scientific Ltd offers a portable H. pylori diagnostic device, HYscreen, which detects ammonia in exhaled air as a biomarker for H. pylori. It has a rapid diagnosis, higher accuracy, lower cost, greater simplicity and convenience. It has the following innovation features: a mouthpiece breath entrapment sampling system, a thermal oxidizer and a Nitrogen Oxide (NO) sensor. This solution is aimed at primary and secondary care in Europe and USA and population screening programs in Asia, answering the call for a cheaper, quicker and simpler monitoring device. This will lead to improved clinical decisions that will facilitate early treatment of the infection, preventing H pylori related cases of gastric cancer and gastric or duodenal ulcers. Consequently, Europe-wide and global savings of up to €1.5 billion and €5.66 billion respectively will be realized by avoiding unnecessary endoscopies, biopsies, expensive H. pylori tests and the healthcare bill from H. pylori-related conditions. Ultimately, HYscreen will open doors for fast and affordable population wide screening. The test will use cheaper C12 urea, though work still needs to be done to make it commercially available. There is a challenge to shorten the thermal oxidizer system for better aesthetics and to reduce ammonia absorption. In Phase 1, we study the feasibility of optimizing the thermal oxidizer system, the use and optimization of C12 urea, protection of the product and the detailed business plan. Phase 2 will produce the final product from the prototype along with the validation steps and clinical trials.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HYSCREEN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HYSCREEN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

HAP2 (2020)

Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

Read More  

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More  

INADVANCE (2019)

Patient-centred pathways of early palliative care, supportive ecosystems and appraisal standard

Read More